5 Biotechs Awaiting FDA Decisions in January 2018 Post author:Sam Post published:December 27, 2017 Post category:BioPharma From 1997 through 2013, there was an average of 27 novel drugs approved in the U.S. per year. Source: BioSpace You Might Also Like Almirall Discontinues R&D for Two Drugs in the U.S. September 28, 2017 Voyager Sinks as Sanofi Genzyme Opts Out of Parkinson's Gene Therapy Program October 30, 2017 LEO Pharma Appoints To Lead US Business June 22, 2017